Search Results for: opdivo

Opdivo (Nivolumab)

Opdivo (nivolumab), a drug developed by Bristol-Myers Squibb, is used to treat melanoma and cancers of the lung, blood, kidney, head and neck, and bladder. In non-small cell lung cancer (NSCLC), ... Read more


TG4010 is an immunotherapy cancer vaccine being developed by Transgene for the treatment of non-small cell lung cancer (NSCLC). How TG4010 works Some cells have a protein called MUC1 on ... Read more

Targeted Cancer Therapies

A targeted cancer therapy is a drug that treats cancer by interacting with a specific molecule that is, for example, involved in the growth, progression or spread of cancer. ... Read more

Immunotherapy for Lung Cancer

A common treatment used for lung cancer is immunotherapy. Immunotherapy drugs harness the body’s own immune system, allowing it to recognize and fight the cancer. Many immunotherapy approaches have ... Read more